1. MARKETS
  2. SECTOR : PHARMACEUTICALS & BIOTECHNOLOGY
  3. INDUSTRY : PHARMACEUTICALS
  4. CIPLA LTD.
Ask MarketMind AI
1441.60 22.90 (1.61%)
1.5M
NSE+BSE Volume

NSE 20 Jul, 2026 3:31 PM (IST)

Watchlist

Portfolio

Alert

US FDA Observation
Cipla subsidiary's New York facility receives a Form 483 with one observation from the US FDA See details

Cipla quarterly and annual financials: results, revenue, profit, P&L, balance sheet, cash flow, financial ratios, revenue mix, peer comparison, and financial documents